Avondale Wealth Management Has $85,000 Stock Position in The Joint Corp. (NASDAQ:JYNT)

Avondale Wealth Management lessened its stake in shares of The Joint Corp. (NASDAQ:JYNT) by 63.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,000 shares of the company’s stock after selling 13,750 shares during the quarter. Avondale Wealth Management owned 0.05% of Joint worth $85,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. O Brien Greene & Co. Inc boosted its stake in Joint by 0.9% in the second quarter. O Brien Greene & Co. Inc now owns 115,620 shares of the company’s stock worth $1,626,000 after purchasing an additional 1,000 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in shares of Joint by 5.4% in the third quarter. BNP Paribas Financial Markets now owns 22,510 shares of the company’s stock valued at $258,000 after buying an additional 1,156 shares during the last quarter. FMR LLC lifted its position in Joint by 38.0% during the 3rd quarter. FMR LLC now owns 10,787 shares of the company’s stock worth $123,000 after buying an additional 2,971 shares in the last quarter. Geode Capital Management LLC grew its holdings in Joint by 1.1% during the 3rd quarter. Geode Capital Management LLC now owns 291,581 shares of the company’s stock worth $3,336,000 after acquiring an additional 3,043 shares during the last quarter. Finally, Douglass Winthrop Advisors LLC grew its holdings in Joint by 4.1% during the 3rd quarter. Douglass Winthrop Advisors LLC now owns 146,400 shares of the company’s stock worth $1,675,000 after acquiring an additional 5,800 shares during the last quarter. Institutional investors and hedge funds own 76.88% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on JYNT shares. StockNews.com upgraded shares of Joint from a “hold” rating to a “buy” rating in a research report on Friday, November 15th. Roth Mkm reduced their price objective on Joint from $16.00 to $15.00 and set a “buy” rating on the stock in a report on Friday, November 8th.

Joint Price Performance

Shares of NASDAQ JYNT traded up $0.03 during mid-day trading on Friday, hitting $10.20. The company’s stock had a trading volume of 37,563 shares, compared to its average volume of 33,861. The Joint Corp. has a one year low of $8.94 and a one year high of $17.82. The company’s fifty day simple moving average is $11.08 and its 200-day simple moving average is $11.75. The stock has a market cap of $152.84 million, a price-to-earnings ratio of -8.95 and a beta of 1.60.

About Joint

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.